Bioequivalence of Testosterone Transdermal Gel in Healthy Female Subjects

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2022-501514-56-00

Acronym

BLCL-TES-EU-01

Enrollment

Registered

2023-01-30

Start date

2023-05-02

Completion date

2023-07-31

Last updated

2023-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Male hypogonadism

None listed

Sex/Gender

All

Age

18 Years to No maximum

Portugal

None listed

Source: EU CTIS · Data processed: Feb 4, 2026